Takeda Pharmaceutical
Christophe Weber is President and Chief Executive Officer of Takeda Pharmaceutical Company Ltd. He joined Takeda in April 2014 as Chief Operating Officer, was named President and Representative Director in June 2014 and was subsequently appointed Chief Executive Officer in April 2015.
Mr. Weber has introduced key transformations within the global organization which focus on the underlying principles of patient- and customer-centricity, accountability and being as agile as possible for a global company. These critical changes will help secure a strong and sustainable future for Takeda.
Mr. Weber has held leadership roles across many different businesses and geographies. Prior to joining Takeda, Mr. Weber held positions of increasing responsibility at GlaxoSmithKline (GSK) including President & General Manager at GSK Vaccines, CEO of GSK Biologicals SA in Belgium, and member of the GSK global Corporate Executive Team. From 2008 to 2010, Mr. Weber served as Asia Pacific SVP and Regional Director at GSK Asia Pacific in Singapore.
Mr. Weber holds a doctorate in pharmacy and pharmacokinetics from the University of Lyon, France. There, he also earned master’s degrees in pharmaceutical marketing and in accounting and finance, as well as a bachelor’s degree in statistics.
This person is not in any offices
Takeda Pharmaceutical
173 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.